McKesson Corporation
Financials
Valuation Metrics
McKesson Corporation's Market Cap is $99.14B. At end of 2025 it was $100.98B. Ranked #153 of 3,111 in US market (top 5%), #105 of 1,666 on NYSE (top 6%), #9 of 206 in Health Care Equipment & Services (top 4%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $99.14B | US#153/3,111 Sec#9/206 |
| Revenue | $403.43B | US#8/3,111 Sec#3/206 |
| Net Income | $4.76B | US#148/3,111 Sec#8/206 |
| Total Assets | $82.32B | US#220/3,111 Sec#10/206 |
| Net Assets | $-2.17B | US#3,063/3,111 Sec#207/206 |
| Employees | 43,000 | US#200/3,111 Sec#25/206 |
| Value | ||
| P/E | 20.82x | US#1,120/3,111 Sec#30/206 |
| PEG | 0.62x | US#653/3,111 Sec#25/206 |
| P/S | 0.25x | US#122/3,111 Sec#12/206 |
| EV/EBITDA | 14.79x | US#1,531/3,111 Sec#62/206 |
| FCF Yield | 5.99% | US#1,138/3,111 Sec#53/206 |
| Profitability | ||
| ROA | 5.78% | US#889/3,111 Sec#57/206 |
| Op. Margin | 1.58% | US#2,339/3,111 Sec#119/206 |
| Revenue Growth | 6.02% | US#1,652/3,111 Sec#121/206 |
| Earnings Growth | 33.49% | US#708/3,111 Sec#31/206 |
| Financial Health | ||
| Total Debt | $8.61B | US#450/3,111 Sec#26/206 |
| FCF | $5.94B | US#125/3,111 Sec#9/206 |
| Cash | $3.98B | US#234/3,111 Sec#12/206 |
| Current Ratio | 0.85x | US#2,434/3,111 Sec#199/206 |
| Net Debt/EBITDA | 0.66x | US#871/3,111 Sec#51/206 |
| Dividend | ||
| Div. Yield | 0.38% | US#1,569/3,111 Sec#46/206 |
| Div. Growth | 14.87% | US#345/3,111 Sec#12/206 |
| Performance | ||
| 1Y Return | 18.38% | US#1,335/3,111 Sec#89/206 |
| 1M Return | 4.90% | US#402/3,111 Sec#39/206 |
| From 52W High | -17.44% | US#1,315/3,111 Sec#89/206 |
| 1Y MDD | -27.17% | US#1,158/3,111 Sec#35/206 |
| Trading | ||
| Volume | 1,022,621 shares | US#1,852/3,111 Sec#117/206 |
| Trading Value | $856M | US#188/3,111 Sec#12/206 |
| Per Share | ||
| EPS | $35.23 | US#27/3,111 Sec#2/206 |
Company Info
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.